1 / 4

MoU Status and Roadmap Summary for Collaboration Efficiency

This document provides an overview of the MoU status, actors involved, and commitments for enhanced collaboration within EGEE. It addresses application needs, commitments, and deadlines for specific tasks. Feedback from the Drug Discovery sector is positive, emphasizing the clarity of defined needs and appreciation for the roadmap vision.

gmahurin
Download Presentation

MoU Status and Roadmap Summary for Collaboration Efficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MoU Status and Roadmap F.Jacq CNRS-IN2P3NA4 AWG-CERN 10th March 2005

  2. MoU:Status(1/2) • Reminder: MoU goals • Identification of the main actors in the different organizations (EGEE NA4, NA3, SA1, Application…) in order to work in collaboration • Expression of application needs (CPU, storage, training…) and evaluation of their impacts on EGEE • EGEE and application commitments with deadlines on specific tasks • Document commented by F.Harris, R.Barbera, G.Wormser, A.Mills, D.Fergusson. • Document sent to PEB on 25/02/05, awaiting for additional comments and validation to circulate the document to the applications MoU&User Survey:Status,Issues and Roadmap

  3. MoU:Status(2/2) • Feed back from Drug Discovery • Good feeling about the document • The document helped them to define and quantify more precisely their needs • They appreciate the vision of the roadmap with the commitments from EGEE and from the application partners • The chapter on metrics indicates what they must survey MoU&User Survey:Status,Issues and Roadmap

  4. MoU: Roadmap • Objective : Agreed MoUs with new applications (EGEODE, Comp Chemistry, Earth Sciences (academic and industry), Drug Discovery, Planck, Magic) before Athens (18/04/05) • Deadlines: • Validation of MoU as soon as possible • MoU sent to the applications <18/03/05 • MoU sent to EGEE (NA4, NA3, SA1) <26/03/05 • MoU agreed between EGEE and the application <18/04 /05 • First MoU foreseen with Drug Discovery application MoU&User Survey:Status,Issues and Roadmap

More Related